Tiny sea creature offers new clues to regeneration and aging

The approval is for the first-line treatment of patients with locally advanced or metastatic NSCLC with specific EGFR mutations. Credit: Explode/Shutterstock. AstraZeneca has obtained Health

The FDA this month pub­lished a flur­ry of Fed­er­al Reg­is­ter no­tices ex­plain­ing in­stances when pri­or­i­ty re­view vouch­ers (PRVs) have been re­deemed un­der the rare pe­di­atric